{"id":"https://openalex.org/W103703410","doi":null,"title":"A split-face, double-blind, randomized and placebo-controlled pilot evaluation of a novel oligopeptide for the treatment of recalcitrant melasma.","display_name":"A split-face, double-blind, randomized and placebo-controlled pilot evaluation of a novel oligopeptide for the treatment of recalcitrant melasma.","publication_year":2009,"publication_date":"2009-08-01","ids":{"openalex":"https://openalex.org/W103703410","mag":"103703410","pmid":"https://pubmed.ncbi.nlm.nih.gov/19663110"},"language":"en","primary_location":{"id":"pmid:19663110","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19663110","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039463477","display_name":"Basil M. Hantash","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Basil M Hantash","raw_affiliation_strings":["Elixir Institute of Regenerative Medicine, San Jose, CA 95138, USA. basil@elixirinstitute.org"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Elixir Institute of Regenerative Medicine, San Jose, CA 95138, USA. basil@elixirinstitute.org","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"Felipe Jimenez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Felipe Jimenez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.7714,"has_fulltext":false,"cited_by_count":32,"citation_normalized_percentile":{"value":0.94515424,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"8","issue":"8","first_page":"732","last_page":"5"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11172","display_name":"Dermatologic Treatments and Research","score":0.7846999764442444,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11172","display_name":"Dermatologic Treatments and Research","score":0.7846999764442444,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11144","display_name":"melanin and skin pigmentation","score":0.21389999985694885,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melasma","display_name":"melasma","score":0.9020000100135803},{"id":"https://openalex.org/keywords/oligopeptides","display_name":"oligopeptides","score":0.9700000286102295},{"id":"https://openalex.org/keywords/tyrosinase-inhibition","display_name":"tyrosinase inhibition","score":0.9800000190734863},{"id":"https://openalex.org/keywords/topical-therapy","display_name":"topical treatment","score":0.8709999918937683},{"id":"https://openalex.org/keywords/skin-lightening","display_name":"skin lightening","score":0.5239999890327454},{"id":"https://openalex.org/keywords/facial-aesthetics","display_name":"facial aesthetics","score":0.8450000286102295},{"id":"https://openalex.org/keywords/patient-satisfaction","display_name":"patient satisfaction","score":0.7639999985694885},{"id":"https://openalex.org/keywords/treatment-tolerability","display_name":"treatment tolerability","score":0.699999988079071}],"concepts":[{"id":"https://openalex.org/C2776677263","wikidata":"https://www.wikidata.org/wiki/Q305190","display_name":"Melasma","level":2,"score":0.9730009436607361},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8903394341468811},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.6669356226921082},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5461665987968445},{"id":"https://openalex.org/C2777063393","wikidata":"https://www.wikidata.org/wiki/Q77776","display_name":"Irritation","level":2,"score":0.5113648772239685},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.48795264959335327},{"id":"https://openalex.org/C2780846639","wikidata":"https://www.wikidata.org/wiki/Q3749115","display_name":"Phototype","level":2,"score":0.4623952805995941},{"id":"https://openalex.org/C2776768635","wikidata":"https://www.wikidata.org/wiki/Q3427301","display_name":"Volunteer","level":2,"score":0.46123671531677246},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21026813983917236},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.1060895323753357},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.06237703561782837},{"id":"https://openalex.org/C6557445","wikidata":"https://www.wikidata.org/wiki/Q173113","display_name":"Agronomy","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000279","descriptor_name":"Administration, Cutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005145","descriptor_name":"Face","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008548","descriptor_name":"Melanosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017060","descriptor_name":"Patient Satisfaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:19663110","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19663110","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Journal Article"},{"id":"mag:103703410","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19663110","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9789000153541565,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":5,"referenced_works":["https://openalex.org/W2055984976","https://openalex.org/W2136749204","https://openalex.org/W2149250648","https://openalex.org/W2402371962","https://openalex.org/W2417184679"],"related_works":["https://openalex.org/W81820604","https://openalex.org/W3016399635","https://openalex.org/W2016165863","https://openalex.org/W2945989165","https://openalex.org/W3025711056","https://openalex.org/W2256745465","https://openalex.org/W4318614941","https://openalex.org/W2916881945","https://openalex.org/W3207842551","https://openalex.org/W3160894884"],"abstract_inverted_index":{"Melasma":[0],"is":[1],"a":[2,65],"cutaneous":[3],"disorder":[4],"associated":[5,31],"with":[6,71,111,135],"an":[7],"overproduction":[8],"of":[9,33,37,51,55,95,115,129,150],"melanin":[10],"by":[11],"the":[12,30,49,82,127,142,148],"tyrosinase":[13,28],"enzyme.":[14],"A":[15],"proprietary":[16],"oligopeptide":[17,57,143],"(Lumixyl)":[18],"was":[19,46,98,108],"previously":[20],"shown":[21],"to":[22,47],"competitively":[23],"inhibit":[24],"mushroom":[25],"and":[26,42,75,80,87,102,131,152],"human":[27],"without":[29],"toxicity":[32],"hydroquinone.":[34],"The":[35],"aim":[36],"this":[38,56],"split-face,":[39],"randomized,":[40],"double-blind":[41],"placebo-controlled":[43],"pilot":[44],"study":[45],"determine":[48],"effect":[50],"twice-daily":[52],"topical":[53],"application":[54],"(0.01%":[58],"w/w)":[59],"on":[60],"moderate,":[61],"recalcitrant":[62,77],"melasma":[63,78,86,130,151],"over":[64],"16-week":[66],"course.":[67],"Five":[68],"female":[69],"participants":[70,121],"Fitzpatrick":[72],"phototype":[73],"IV":[74],"moderate":[76],"enrolled":[79],"completed":[81],"study.":[83],"Improvement":[84],"in":[85,126,147],"overall":[88,132],"facial":[89,133],"aesthetics":[90,134],"as":[91,93],"well":[92,109],"assessment":[94],"volunteer":[96],"satisfaction":[97],"measured":[99],"using":[100],"10-":[101],"five-point":[103],"grading":[104],"scales,":[105],"respectively.":[106],"Treatment":[107],"tolerated":[110],"no":[112],"visible":[113],"signs":[114],"irritation":[116],"or":[117],"allergy.":[118],"All":[119],"five":[120],"demonstrated":[122],"statistically":[123],"significant":[124],"improvement":[125],"appearance":[128],"high":[136],"patient":[137],"satisfaction.":[138],"Results":[139],"suggest":[140],"that":[141],"may":[144],"be":[145],"useful":[146],"treatment":[149],"warrants":[153],"further":[154],"evaluation.":[155]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}